Visit https://www.peervoice.com/ESR860 to view the entire programme with slides. After completing “Evolving Treatment Paradigm in Early-Stage EGFR-Mutant NSCLC: A Primer for Medical Oncologists”, participants will be able to: Discuss recent clinical data on the management of early-stage EGFR-mutant NSCLC; Explain best practices for mutational testing in patients with early-stage EGFR-mutant NSCLC; Develop strategies to improve communication and collaboration among the multidisciplinary team.